Results 231 to 240 of about 2,221,794 (256)
Some of the next articles are maybe not open access.

Decitabine for acute myeloid leukemia

Expert Review of Anticancer Therapy, 2012
Decitabine (Dacogen(®), Eisai Inc., NJ, USA) is a nucleoside analogue DNA methyltransferase inhibitor first synthesized and documented to have antileukemic efficacy over 40 years ago. Over the years, the dosing of decitabine has been refined, such that for acute myeloid leukemia, a 5-day schedule of 20 mg/m(2) is now commonly utilized.
openaire   +2 more sources

Acute Myeloid Leukemia

New England Journal of Medicine, 2015
Hartmut, Döhner   +2 more
openaire   +2 more sources

Epigenetics in Acute Myeloid Leukemia

Medical Epigenetics, 2021
Carmela Dell'Aversana   +2 more
exaly  

Therapeutics and DNA Methylation Inhibitors

Medical Epigenetics, 2021
Shyamala C Navada
exaly  

Acute myeloid leukemia

2016
Arlene Redner, Rachel Kessel
openaire   +1 more source

Onconephrology: The Intersections Between the Kidney and Cancer

Ca-A Cancer Journal for Clinicians, 2021
Blaithin A McMahon   +2 more
exaly  

Epigenetics in Acute Myeloid Leukemia

Medical Epigenetics, 2016
Carmela Dell'Aversana, Lucia Altucci
exaly  

Chemotherapy of Acute Leukemia

Ca-A Cancer Journal for Clinicians, 1964
E Frei
exaly  

Treatment of Acute Leukemia:Current Results, and Analysis of What We Can Do Now

Ca-A Cancer Journal for Clinicians, 1964
Margaret P Sullivan, Wataru W Sutow
exaly  

Acute Leukemia in Adults: Recent Developments in Diagnosis and Treatment

Ca-A Cancer Journal for Clinicians, 1994
Steven M Devine, Richard A. Larson
exaly  

Home - About - Disclaimer - Privacy